Sobre a EDCTP
We are in the process of launching our new website. Please come back later to check it out.
A Parceria entre a Europa e os Países em Desenvolvimento para a Realização de Ensaios Clínicos (EDCTP) tem por objectivo acelerar o desenvolvimento de fármacos, vacinas, microbicidas e diagnósticos novos ou melhorados para o VIH/SIDA, a tuberculose e a malária, com particular incidência em ensaios clínicos da fase II e III na África subsaariana.
Portuguese title
Descubra a estratégia da EDCTP na luta contra HIV/AIDS, tuberculose e malária.
Portuguese title
Descubra a estratégia da EDCTP na luta contra HIV/AIDS, tuberculose e malária.
Portuguese title
Descubra a estratégia da EDCTP na luta contra HIV/AIDS, tuberculose e malária.
Latest news
PanACEA 2: New TB drug tested in patients for the first time in South Africa
The new promising tuberculosis drug BTZ-043 has been administered to patients for the first time in Cape Town, South Africa. This clinical study which is led by Professor Michael Hoeslcher of the Tropical Institute at the Hospital of the Ludwig-Maximilians…
World AIDS day 2019: Clinical research that reaches key populations
According to World Health Organization (WHO) statistics, in 2018 an estimated 1.7 million people were newly infected with HIV and there were 0.8 million HIV-related deaths. Most of these deaths are in low and middle-income countries, particularly in sub-Saharan Africa,…